Condition: Analgesics, Opioid · Anesthesia, Spinal · Total Hip Replacement · Sponsor: Medical University of Silesia
Pain management after total hip replacement is one of the most important aspects of postoperative care for patients and clinicians alike. One of the most common techniques used in anesthesia for this procedure is spinal anesthesia with concurrent administration of opioids into spinal sac. Addition of opioids not only prolongs the anesthesia but also provides pain relief after the procedure for a limited amount of time. Because of its unique chemical properties morphine provides the longest pain relief amongst currently known opioids lasting up to 24 hours. Unfortunately this beneficial effect is associated with both minor and serious adverse effects, most important of which is respiratory depression. To limit this potenitialy fatal adverse effect dosing of morphine must be very precise in order to balance advantages and risks. The aim of the study was to assess effectiveness and safety profile of different doses of morphine administered during spinal anesthesia for pain control.
This description comes directly from the study's public registry record.
Szymon Białka, MD PhD · +48323407593 · szymon.bialka@gmail.com
Jakub Żak, MD · +48607936667 · jakubzak.sum@gmail.com
Always discuss trial participation with your own doctor first.
| Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary | Sosnowiec, Silesian Voivodeship, Poland | Recruiting |
| Uniwersytecki Szpital Kliniczny nr 1 im. prof. Tadeusza Sokołowskiego PUM w Szczecinie | Szczecin, West Pomeranian Voivodeship, Poland | Not Yet Recruiting |
| Zespół Opieki Zdrowotnej w Końskich | Gmina Końskie, Świętokrzyskie Voivodeship, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06878014